This is based on the avg CSL sp. Admittedly they have a range of products, but the estimated antibiotic market value by mid 2020s is something like $60 billion by itself. If recce achieve everything they are setting out to do, $10 billion is a start. I don't think they will say yes to a takeover. More likely they will just license to other pharmaceutical companies.
This is based on the avg CSL sp. Admittedly they have a range of...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $35.37K | 121.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111103 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 5593 | 3 |
View Market Depth
| Last trade - 15.13pm 24/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |